SHANE FARR: Open Payments
NPI 1831548098 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,712 in 178 payments from 20 companies in 2025. Trend: 2023 $1,557 · 2024 $3,051 · 2025 $6,712
Food & beverage: $2,375Travel & lodging: $2,291Consulting: $1,800Education: $247
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 36 | $4,573 |
| Janssen Biotech, Inc. | 12 | $346 |
| Novartis Pharmaceuticals Corporation | 19 | $264 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 18 | $251 |
| ABBVIE INC. | 21 | $229 |
| Galderma Laboratories, L.P. | 22 | $217 |
| PFIZER INC. | 17 | $172 |
| GENZYME CORPORATION | 4 | $169 |
| UCB, Inc. | 9 | $141 |
| LEO Pharma Inc. | 4 | $99 |
Products named: Zoryve, TREMFYA, COSENTYX, DUPIXENT, NEMLUVIO, SKYRIZI, Bimzelx, LITFULO.
Industry payments across UT — which companies pay providers there.
